JP2023548005A5 - - Google Patents
Info
- Publication number
- JP2023548005A5 JP2023548005A5 JP2023521103A JP2023521103A JP2023548005A5 JP 2023548005 A5 JP2023548005 A5 JP 2023548005A5 JP 2023521103 A JP2023521103 A JP 2023521103A JP 2023521103 A JP2023521103 A JP 2023521103A JP 2023548005 A5 JP2023548005 A5 JP 2023548005A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- chain variable
- antibody
- antigen
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063106853P | 2020-10-28 | 2020-10-28 | |
| US202063106855P | 2020-10-28 | 2020-10-28 | |
| US63/106,855 | 2020-10-28 | ||
| US63/106,853 | 2020-10-28 | ||
| US202063122720P | 2020-12-08 | 2020-12-08 | |
| US63/122,720 | 2020-12-08 | ||
| PCT/US2021/057150 WO2022094152A1 (en) | 2020-10-28 | 2021-10-28 | Anti-transthyretin antibodies and methods of use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023548005A JP2023548005A (ja) | 2023-11-15 |
| JP2023548005A5 true JP2023548005A5 (https=) | 2024-10-31 |
Family
ID=81384336
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023521103A Pending JP2023548005A (ja) | 2020-10-28 | 2021-10-28 | 抗トランスサイレチン抗体およびその使用方法 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20230391859A1 (https=) |
| EP (1) | EP4237005A4 (https=) |
| JP (1) | JP2023548005A (https=) |
| WO (1) | WO2022094152A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4619431A1 (en) * | 2022-11-15 | 2025-09-24 | Neurimmune AG | Methods for treating or preventing transthyretin-mediated amyloidosis |
| EP4727650A1 (en) * | 2023-06-14 | 2026-04-22 | Immutrin Ltd | Anti-fibril antibodies |
| AR134700A1 (es) | 2023-12-15 | 2026-03-04 | Novo Nordisk As | Formulaciones líquidas estables |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10213506B2 (en) * | 2014-08-26 | 2019-02-26 | University Of Tennessee Research Foundation | Targeting immunotherapy for amyloidosis |
| CN113599539A (zh) * | 2014-08-29 | 2021-11-05 | 阿尔尼拉姆医药品有限公司 | 治疗甲状腺素运载蛋白（ttr）介导的淀粉样变性的方法 |
| TWI786505B (zh) * | 2015-01-28 | 2022-12-11 | 愛爾蘭商普羅佘納生物科技有限公司 | 抗甲狀腺素運送蛋白抗體 |
| PT3329002T (pt) * | 2015-07-31 | 2021-01-12 | Alnylam Pharmaceuticals Inc | Composições de iarn de transtirretina (ttr) e métodos de seu uso para tratamento ou prevenção de doenças associadas à ttr |
| WO2018007922A2 (en) * | 2016-07-02 | 2018-01-11 | Prothena Biosciences Limited | Anti-transthyretin antibodies |
| WO2018007924A2 (en) * | 2016-07-02 | 2018-01-11 | Prothena Biosciences Limited | Anti-transthyretin antibodies |
| US11382974B2 (en) * | 2017-08-01 | 2022-07-12 | The Trustees Of Columbia University In The City Of New York | Methods and compositions for treatment of amyloid deposition diseases |
| EP3688161A1 (en) * | 2017-09-29 | 2020-08-05 | Intellia Therapeutics, Inc. | Compositions and methods for ttr gene editing and treating attr amyloidosis |
| PE20211453A1 (es) * | 2017-11-29 | 2021-08-05 | Prothena Biosciences Ltd | Formulacion liofilizada de un anticuerpo monoclonal contra transtirretina |
-
2021
- 2021-10-28 JP JP2023521103A patent/JP2023548005A/ja active Pending
- 2021-10-28 US US18/033,568 patent/US20230391859A1/en active Pending
- 2021-10-28 EP EP21887569.8A patent/EP4237005A4/en active Pending
- 2021-10-28 WO PCT/US2021/057150 patent/WO2022094152A1/en not_active Ceased